4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000899243-20-030412
Chief Executive Officer acquired 13,931 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2020-11-02 | Conversion | +13,931 | 39,928 | D | ||
| Derivatives | |||||||
| Schambye Hans T. Chief Executive Officer | 2020-06-24 | Grant or award · Stock Option (right to buy) | +207,976 | 207,976 | D | ||
| Schambye Hans T. Chief Executive Officer | 2020-10-07 | Grant or award · Stock Option (right to buy) | +519,940 | 519,940 | D | ||
| Schambye Hans T. Chief Executive Officer | 2020-11-02 | Conversion · Series C-1 Preferred Stock | −5,359 | 0 | D | ||
Loading xslF345X03/doc4.xml…